DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Clinical trial NCT03115333 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03115333
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-25
- Primary completion
- 2025-12-31
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.